Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+3.61%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$103B
AUM Growth
+$9.68B
(+10%)
Cap. Flow
+$7.53B
Cap. Flow
% of AUM
7.29%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
1,619
New
26
Increased
800
Reduced
164
Closed
25
Top Buys
| 1 |
Apple
AAPL
|
+$579M |
| 2 |
NVIDIA
NVDA
|
+$486M |
| 3 |
Microsoft
MSFT
|
+$433M |
| 4 |
Amazon
AMZN
|
+$280M |
| 5 |
Procter & Gamble
PG
|
+$269M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$140M |
| 2 |
Texas Instruments
TXN
|
+$82M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$50.1M |
| 4 |
Amgen
AMGN
|
+$24.5M |
| 5 |
Tradeweb Markets
TW
|
+$23.3M |
Sector Composition
| 1 | Technology | 31.77% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Accuray
ARAY
$175M
| $261K | ﹤0.01% |
125,942
-12,263
| -9% | -$25.4K |
|
952
Riot Platforms
RIOT
$6.06B
| $260K | ﹤0.01% |
21,084
+4,507
| +27% | +$55.6K |
|
953
ACI Worldwide
ACIW
$5.17B
| $258K | ﹤0.01% |
4,855
-561
| -10% | -$29.9K |
|
954
Paymentus
PAY
$4.41B
| $258K | ﹤0.01% |
7,379
-1,689
| -19% | -$59.1K |
|
955
Xencor
XNCR
$596M
| $257K | ﹤0.01% |
10,657
-780
| -7% | -$18.8K |
|
|
PKST
956
Peakstone Realty Trust
PKST
$485M
| $257K | ﹤0.01% |
22,620
| – | – |
|
957
Rocket Pharmaceuticals
RCKT
$343M
| $254K | ﹤0.01% |
20,196
+8,190
| +68% | +$103K |
|
|
LX
958
LexinFintech Holdings
LX
$973M
| $254K | ﹤0.01% |
41,567
+16,274
| +64% | +$99.3K |
|
959
Euronet Worldwide
EEFT
$3.57B
| $248K | ﹤0.01% |
2,435
+771
| +46% | +$78.7K |
|
960
Fluence Energy
FLNC
$886M
| $247K | ﹤0.01% |
14,227
-3,889
| -21% | -$67.5K |
|
961
dLocal
DLO
$4.02B
| $244K | ﹤0.01% |
21,283
-1,683
| -7% | -$19.3K |
|
962
Beam Therapeutics
BEAM
$2.01B
| $244K | ﹤0.01% |
9,613
-995
| -9% | -$25.3K |
|
963
Ultragenyx Pharmaceutical
RARE
$3.02B
| $243K | ﹤0.01% |
5,849
-712
| -11% | -$29.5K |
|
964
Arcturus Therapeutics
ARCT
$489M
| $241K | ﹤0.01% |
13,461
+4,647
| +53% | +$83.4K |
|
965
Merus
MRUS
$5.08B
| $241K | ﹤0.01% |
5,590
-427
| -7% | -$18.4K |
|
966
Core Scientific
CORZ
$4.88B
| $241K | ﹤0.01% |
+15,647
| New | +$241K |
|
967
Neurogene
NGNE
$265M
| $239K | ﹤0.01% |
10,290
+4,334
| +73% | +$101K |
|
968
Arbutus Biopharma
ABUS
$886M
| $238K | ﹤0.01% |
69,660
-12,287
| -15% | -$42K |
|
969
Marqeta
MQ
$2.64B
| $234K | ﹤0.01% |
60,674
+28,663
| +90% | +$111K |
|
|
HPP
970
Hudson Pacific Properties
HPP
$1.1B
| $234K | ﹤0.01% |
80,678
| – | – |
|
971
Wave Life Sciences
WVE
$1.18B
| $231K | ﹤0.01% |
17,109
-24,511
| -59% | -$331K |
|
972
Shopify
SHOP
$185B
| $231K | ﹤0.01% |
2,114
-580
| -22% | -$63.4K |
|
973
Iovance Biotherapeutics
IOVA
$861M
| $227K | ﹤0.01% |
29,684
+4,192
| +16% | +$32.1K |
|
974
Azenta
AZTA
$1.34B
| $225K | ﹤0.01% |
4,446
+576
| +15% | +$29.1K |
|
|
AUTL
975
Autolus Therapeutics
AUTL
$367M
| $221K | ﹤0.01% |
82,411
+14,432
| +21% | +$38.7K |
|